다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, v.12 no.2, 2014년, pp.75 - 82
Nakajima, Akira (Department of Neuropsychopharmacology and Hospital Pharmacy, Graduate School of Medicine, Nagoya University, Nagoya, Japan.) , Ohizumi, Yasushi (Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.) , Yamada, Kiyofumi (Department of Neuropsychopharmacology and Hospital Pharmacy, Graduate School of Medicine, Nagoya University, Nagoya, Japan.)
AI-Helper
Alzheimer's disease (AD), the most common form of dementia among the elderly, is characterized by the progressive decline of cognitive function and has a detrimental impact worldwide. Despite intensive laboratory and clinical research over the last three decades, pharmacological options for the prev...
1 Wimo A Prince M World Alzheimer Report 2010: the global economic impact of dementia Alzheimer's Disease International 2010 1 56
2 Cummings JL Alzheimer's disease N Engl J Med 2004 351 56 67 15229308
3 Osborn GG Saunders AV Current treatments for patients with Alzheimer disease J Am Osteopath Assoc 2010 110 9 Suppl 8 S16 S26 20926739
4 Huang Y Mucke L Alzheimer mechanisms and therapeutic strategies Cell 2012 148 1204 1222 22424230
5 Li JW Vederas JC Drug discovery and natural products: end of an era or an endless frontier? Science 2009 325 161 165 19589993
6 Ohizumi Y Application of physiologically active substances isolated from natural resources to pharmacological studies Jpn J Pharmacol 1997 73 263 289 9165364
7 Nagase H Omae N Omori A Nakagawasai O Tadano T Yokosuka A Nobiletin and its related flavonoids with CRE-dependent transcription-stimulating and neuritegenic activities Biochem Biophys Res Commun 2005 337 1330 1336 16253614
8 Nagase H Yamakuni T Matsuzaki K Maruyama Y Kasahara J Hinohara Y Mechanism of neurotrophic action of nobiletin in PC12D cells Biochemistry 2005 44 13683 13691 16229458
9 Matsuzaki K Miyazaki K Sakai S Yawo H Nakata N Moriguchi S Nobiletin, a citrus flavonoid with neurotrophic action, augments protein kinase A-mediated phosphorylation of the AMPA receptor subunit, GluR1, and the postsynaptic receptor response to glutamate in murine hippocampus Eur J Pharmacol 2008 578 194 200 17976577
10 Auld DS Kornecook TJ Bastianetto S Quirion R Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies Prog Neurobiol 2002 68 209 245 12450488
11 Schliebs R Arendt T The cholinergic system in aging and neuronal degeneration Behav Brain Res 2011 221 555 563 21145918
12 Hozumi S Nakagawasai O Tan-No K Niijima F Yamadera F Murata A Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy Behav Brain Res 2003 138 9 15 12493626
13 Yamamoto T Jin J Watanabe S Characteristics of memory dysfunction in olfactory bulbectomized rats and the effects of cholinergic drugs Behav Brain Res 1997 83 57 62 9062661
14 Bobkova NV Garbuz DG Nesterova I Medvinskaya N Samokhin A Alexandrova I Therapeutic effect of exogenous hsp70 in mouse models of Alzheimer's disease J Alzheimers Dis 2014 38 425 435 23985416
15 Peters JM Hummel T Kratzsch T Lötsch J Skarke C Frölich L Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques Am J Psychiatry 2003 160 1995 2002 14594747
16 Djordjevic J Jones-Gotman M De Sousa K Chertkow H Olfaction in patients with mild cognitive impairment and Alzheimer's disease Neurobiol Aging 2008 29 693 706 17207898
17 Nakajima A Yamakuni T Haraguchi M Omae N Song SY Kato C Nobiletin, a citrus flavonoid that improves memory impairment, rescues bulbectomy-induced cholinergic neurodegeneration in mice J Pharmacol Sci 2007 105 122 126 17895593
18 Heckers S Ohtake T Wiley RG Lappi DA Geula C Mesulam MM Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor J Neurosci 1994 14 1271 1289 8120624
19 Tarricone BJ Simon JR Low WC Intrahippocampal transplants of septal cholinergic neurons: choline acetyltransferase activity, muscarinic receptor binding, and spatial memory function Brain Res 1993 632 41 47 8149244
20 Hardy J Selkoe DJ The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 2002 297 353 356 12130773
21 Van Dam D De Deyn PP Animal models in the drug discovery pipeline for Alzheimer's disease Br J Pharmacol 2011 164 1285 1300 21371009
22 Nitta A Itoh A Hasegawa T Nabeshima T beta-Amyloid protein-induced Alzheimer's disease animal model Neurosci Lett 1994 170 63 66 8086012
23 Yamada K Tanaka T Zou LB Senzaki K Yano K Osada T Long-term deprivation of oestrogens by ovariectomy potentiates beta-amyloid-induced working memory deficits in rats Br J Pharmacol 1999 128 419 427 10510453
24 Matsuzaki K Yamakuni T Hashimoto M Haque AM Shido O Mimaki Y Nobiletin restoring beta-amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer's disease model rats Neurosci Lett 2006 400 230 234 16581185
25 Onozuka H Nakajima A Matsuzaki K Shin RW Ogino K Saigusa D Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease J Pharmacol Exp Ther 2008 326 739 744 18544674
26 Shin RW Ogino K Shimabuku A Taki T Nakashima H Ishihara T Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau Acta Neuropathol 2007 113 627 636 17431643
27 Das SR Magnusson KR Changes in expression of splice cassettes of NMDA receptor GluN1 subunits within the frontal lobe and memory in mice during aging Behav Brain Res 2011 222 122 133 21443909
28 Brim BL Haskell R Awedikian R Ellinwood NM Jin L Kumar A Memory in aged mice is rescued by enhanced expression of the GluN2B subunit of the NMDA receptor Behav Brain Res 2013 238 211 226 23103326
29 Huang YJ Lin CH Lane HY Tsai GE NMDA neurotransmission dysfunction in behavioral and psychological symptoms of Alzheimer's disease Curr Neuropharmacol 2012 10 272 285 23450042
30 Mishizen-Eberz AJ Rissman RA Carter TL Ikonomovic MD Wolfe BB Armstrong DM Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology Neurobiol Dis 2004 15 80 92 14751773
31 Sze C Bi H Kleinschmidt-DeMasters BK Filley CM Martin LJ N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease J Neurol Sci 2001 182 151 159 11137521
32 Procter AW Wong EH Stratmann GC Lowe SL Bowen DM Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer's disease J Neurochem 1989 53 698 704 2569500
33 Snyder EM Nong Y Almeida CG Paul S Moran T Choi EY Regulation of NMDA receptor trafficking by amyloid-beta Nat Neurosci 2005 8 1051 1058 16025111
34 Nakajima A Yamakuni T Matsuzaki K Nakata N Onozuka H Yokosuka A Nobiletin, a citrus flavonoid, reverses learning impairment associated with N-methyl-D-aspartate receptor antagonism by activation of extracellular signal-regulated kinase signaling J Pharmacol Exp Ther 2007 321 784 790 17289833
35 Cammarota M Bevilaqua LR Ardenghi P Paratcha G Levi de Stein M Izquierdo I Learning-associated activation of nuclear MAPK, CREB and Elk-1, along with Fos production, in the rat hippocampus after a one-trial avoidance learning: abolition by NMDA receptor blockade Brain Res Mol Brain Res 2000 76 36 46 10719213
36 Alonso M Viola H Izquierdo I Medina JH Aversive experiences are associated with a rapid and transient activation of ERKs in the rat hippocampus Neurobiol Learn Mem 2002 77 119 124 11749089
37 Sagare AP Bell RD Zlokovic BV Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease Cold Spring Harb Perspect Med 2012 2 doi: 10.1101/cshperspect.a011452
38 Wang X Xing A Xu C Cai Q Liu H Li L Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid-β oligomerization in rats J Alzheimers Dis 2010 21 813 822 20634588
39 Yamamoto Y Shioda N Han F Moriguchi S Nakajima A Yokosuka A Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation Brain Res 2009 1295 218 229 19646972
40 Takeda T Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice Neurochem Res 2009 34 639 659 19199030
41 Butterfield DA Poon HF The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease Exp Gerontol 2005 40 774 783 16026957
42 Tomobe K Nomura Y Neurochemistry, neuropathology, and heredity in SAMP8: a mouse model of senescence Neurochem Res 2009 34 660 669 19247832
43 Nakajima A Aoyama Y Nguyen TT Shin EJ Kim HC Yamada S Nobiletin, a citrus flavonoid, ameliorates cognitive impairment, oxidative burden, and hyperphosphorylation of tau in senescence-accelerated mouse Behav Brain Res 2013 250 351 360 23714077
44 Phillips RG LeDoux JE Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning Behav Neurosci 1992 106 274 285 1590953
45 Ohta A Akiguchi I Seriu N Ohnishi K Yagi H Higuchi K Deterioration in learning and memory of fear conditioning in response to context in aged SAMP8 mice Neurobiol Aging 2001 22 479 484 11378255
46 Sakurai T Ogasawara J Kizaki T Ishibashi Y Fujiwara T Akagawa K Involvement of leucine zipper transcription factor-like protein 1 (Lztfl1) in the attenuation of cognitive impairment by exercise training Biochem Biophys Res Commun 2011 416 125 129 22093827
47 LaBar KS Cabeza R Cognitive neuroscience of emotional memory Nat Rev Neurosci 2006 7 54 64 16371950
48 Sartori SB Hauschild M Bunck M Gaburro S Landgraf R Singewald N Enhanced fear expression in a psychopathological mouse model of trait anxiety: pharmacological interventions PLoS One 2011 6 e16849 21386891
49 Markesbery WR Oxidative stress hypothesis in Alzheimer's disease Free Radic Biol Med 1997 23 134 147 9165306
50 Nomura Y Wang BX Qi SB Namba T Kaneko S Biochemical changes related to aging in the senescence-accelerated mouse Exp Gerontol 1989 24 49 55 2707313
51 Butterfield DA Howard BJ Yatin S Allen KL Carney JM Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alpha-phenylnitrone Proc Natl Acad Sci U S A 1997 94 674 678 9012843
52 Okatani Y Wakatsuki A Reiter RJ Miyahara Y Melatonin reduces oxidative damage of neural lipids and proteins in senescence-accelerated mouse Neurobiol Aging 2002 23 639 644 12009513
53 Nemoto K Ikeda A Yoshida C Kimura J Mori J Fujiwara H Characteristics of nobiletin-mediated alteration of gene expression in cultured cell lines Biochem Biophys Res Commun 2013 431 530 534 23321314
54 Ikeda A Nemoto K Yoshida C Miyata S Mori J Soejima S Suppressive effect of nobiletin, a citrus polymethoxyflavonoid that downregulates thioredoxin-interacting protein expression, on tunicamycin-induced apoptosis in SK-N-SH human neuroblastoma cells Neurosci Lett 2013 549 135 139 23774476
55 Su JD Yen JH Li S Weng CY Lin MH Ho CT 3',4'-didemethylnobiletin induces phase II detoxification gene expression and modulates PI3K/Akt signaling in PC12 cells Free Radic Biol Med 2012 52 126 141 22064360
56 Lu YH Su MY Huang HY Lin-Li Yuan CG Protective effects of the citrus flavanones to PC12 cells against cytotoxicity induced by hydrogen peroxide Neurosci Lett 2010 484 6 11 20691757
57 Goedert M Spillantini MG A century of Alzheimer's disease Science 2006 314 777 781 17082447
58 Bramblett GT Goedert M Jakes R Merrick SE Trojanowski JQ Lee VM Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding Neuron 1993 10 1089 1099 8318230
59 Johnson GV Stoothoff WH Tau phosphorylation in neuronal cell function and dysfunction J Cell Sci 2004 117 5721 5729 15537830
60 Han D Qureshi HY Lu Y Paudel HK Familial FTDP-17 missense mutations inhibit microtubule assembly-promoting activity of tau by increasing phosphorylation at Ser202 in vitro J Biol Chem 2009 284 13422 13433 19304664
61 Cho JH Johnson GV Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules J Neurochem 2004 88 349 358 14690523
62 Goedert M Jakes R Crowther RA Six J Lübke U Vandermeeren M The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development Proc Natl Acad Sci U S A 1993 90 5066 5070 8506352
63 Morishima-Kawashima M Hasegawa M Takio K Suzuki M Yoshida H Titani K Proline-directed and non-proline-directed phosphorylation of PHF-tau J Biol Chem 1995 270 823 829 7822317
64 Rudrabhatla P Jaffe H Pant HC Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs FASEB J 2011 25 3896 3905 21828286
65 Arriagada PV Growdon JH Hedley-Whyte ET Hyman BT Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease Neurology 1992 42 631 639 1549228
66 Berg L McKeel DW Jr Miller JP Storandt M Rubin EH Morris JC Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype Arch Neurol 1998 55 326 335 9520006
67 Giannakopoulos P Kövari E Gold G von Gunten A Hof PR Bouras C Pathological substrates of cognitive decline in Alzheimer's disease Front Neurol Neurosci 2009 24 20 29 19182459
68 Cui Y Wu J Jung SC Park DB Maeng YH Hong JY Anti-neuroinflammatory activity of nobiletin on suppression of microglial activation Biol Pharm Bull 2010 33 1814 1821 21048305
69 Pardridge WM Alzheimer's disease drug development and the problem of the blood-brain barrier Alzheimers Dement 2009 5 427 432 19751922
70 Saigusa D Shibuya M Jinno D Yamakoshi H Iwabuchi Y Yokosuka A High-performance liquid chromatography with photodiode array detection for determination of nobiletin content in the brain and serum of mice administrated the natural compound Anal Bioanal Chem 2011 400 3635 3641 21559759
71 Asakawa T Hiza A Nakayama M Inai M Oyama D Koide H PET imaging of nobiletin based on a practical total synthesis Chem Commun (Camb) 2011 47 2868 2870 21243163
72 Yasuda T Yoshimura Y Yabuki H Nakazawa T Ohsawa K Mimaki Y Urinary metabolites of nobiletin orally administered to rats Chem Pharm Bull (Tokyo) 2003 51 1426 1428 14646323
73 Li S Wang Z Sang S Huang MT Ho CT Identification of nobiletin metabolites in mouse urine Mol Nutr Food Res 2006 50 291 299 16521176
74 Al Rahim M Nakajima A Saigusa D Tetsu N Maruyama Y Shibuya M 4'-Demethylnobiletin, a bioactive metabolite of nobiletin enhancing PKA/ERK/CREB signaling, rescues learning impairment associated with NMDA receptor antagonism via stimulation of the ERK cascade Biochemistry 2009 48 7713 7721 19601643
75 Lee J Bogyo M Target deconvolution techniques in modern phenotypic profiling Curr Opin Chem Biol 2013 17 118 126 23337810
76 Futamura Y Muroi M Osada H Target identification of small molecules based on chemical biology approaches Mol Biosyst 2013 9 897 914 23354001
77 Seki T Kamiya T Furukawa K Azumi M Ishizuka S Takayama S Nobiletin-rich Citrus reticulata peels, a kampo medicine for Alzheimer's disease: a case series Geriatr Gerontol Int 2013 13 236 238 23286569
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.